Related Experiment Videos
Rash complicating carbamazepine treatment
K G Kramlinger1, K A Phillips, R M Post
1Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20892.
Journal of Clinical Psychopharmacology
|December 1, 1994
Summary
Carbamazepine rash is a common side effect, affecting 12% of patients. While often benign, these carbamazepine-induced rashes can sometimes become severe and life-threatening.
Area of Science:
- Dermatology
- Pharmacology
- Neurology
Background:
- Carbamazepine is a widely prescribed medication for trigeminal neuralgia, seizure disorders, and bipolar disorder.
- While generally safe, potential adverse reactions require ongoing investigation.
- Carbamazepine-induced rash is a notable side effect that warrants further characterization.
Purpose of the Study:
- To investigate the incidence and clinical characteristics of carbamazepine-induced rash.
- To identify demographic features and laboratory findings associated with this adverse reaction.
- To discuss potential mechanisms and treatment implications for carbamazepine-induced eruptions.
Main Methods:
- Retrospective analysis of 113 patients treated with carbamazepine.
- Clinical observation and documentation of rash characteristics.
- Review of associated laboratory findings and patient demographics.
Main Results:
- Carbamazepine-induced rash occurred in 13% (12 out of 113) of patients.
- Detailed clinical, demographic, and laboratory data were collected for affected individuals.
- Findings were integrated with existing literature on carbamazepine-induced dermatologic reactions.
Conclusions:
- Carbamazepine-induced rash is a common adverse effect.
- Understanding the clinical spectrum is crucial for appropriate management.
- Early recognition is important as rashes can escalate to severe, life-threatening conditions.